EVENT DETAILS
Wednesday, May 1, 2019
Hilton Boston/Woburn
2 Forbes Road, Woburn, MA 01810
Dates
8:00 AM - 5:00 PM
Total Credits
7 Contact Hour(s)
Target Audience
Nurse , Pharmacist , Pharmacy Technician
Cost
$129.00
Registration closes on 4/30/2019 at 11:00 PM
Early Registration: $129.00
Cost After 4/10/2019: $149.00
 

Registration
Registration will be held between 8:00a and 8:30a. Upon registering, you will be given a packet containing a Seminar Access Code sheet and an Attendance Verification form. The Seminar Access code sheet will provide you an opportunity to record the evaluation password for each course. This passcode will allow you entry to complete your online activity evaluation at the conclusion of each activity. The Attendance Verification form must be submitted to the registration desk prior to your departure at the end of the day.

Activity Handouts
Activity handouts will NOT be provided at registration. You are asked to download the handouts prior to arriving at the conference. You may save the handouts to your mobile device or laptop, or you may print them, for reference throughout the conference and future use.

Audience Response Questions
TurningPoint technology will be used for interactive audience response questions during each CE activity. You will be asked to participate with your mobile device or laptop.  You can either download the TurningPoint app for your mobile device, or you can simply visit ttpoll.com.  You will be asked to enter the Session ID: AHRevents.  Your audience response questions will automatically appear as they are asked by the faculty.

Earning Credit
An online activity evaluation must be completed for each activity in order to earn CE credit for participation. Upon conclusion of each activity, you may log in to AHRevents.com, hover over CE Activity, and click on Retrieve On-Location Credits. After choosing the correct conference, enter the supplied evaluation passcodes delivered after each CE session to unlock access to the online activity evaluations. After completing the online activity evaluation, you will have earned your CE credit. Please ensure that your NABP ePID and birthdate are updated in your AHR profile for proper submission to CPE Monitor.

Meals
A light continental breakfast will be provided during the morning registration. A plated lunch will be served between the hours of 12:30p and 1:30p. Refreshments and snacks will be provided during the afternoon programs.

 

AGENDA

Scheduled CE Activities Wednesday, May 1, 2019
  
This session will review the basic tenets of pharmacotherapeutic pain management including various types of pain and the classes of medications that are utilized for pain treatment. We will discuss pain syndromes and targeted treatment with co-analgesic and adjuvant pain medications. Case-based discussion of opioid use and management will illustrate drug selection, dosing and side effect management.
 
 
Pharmacist Learning Objectives
  • Recognize the importance of a pain diagnosis and review the types of pain syndromes that palliative patients often have.
  • Identify co-analgesic and adjuvant medications that are available for the treatment of pain.
  • Illustrate the steps of successful opioid management including risk assessment, opioid selection, titration, rotation, assessment, and treatment of side effects.
Pharmacy Technician Learning Objectives
  • Recognize the importance of a pain diagnosis and review the types of pain syndromes that palliative patients often have.
  • Identify co-analgesic and adjuvant medications that are available for the treatment of pain.
  • Illustrate the steps of successful opioid management including risk assessment, opioid selection, titration, rotation, assessment, and treatment of side effects.
Nurse Learning Objectives
  • Recognize the importance of a pain diagnosis and review the types of pain syndromes that palliative patients often have.
  • Identify co-analgesic and adjuvant medications that are available for the treatment of pain.
  • Illustrate the steps of successful opioid management including risk assessment, opioid selection, titration, rotation, assessment, and treatment of side effects.
 
Faculty
Bridget ScullionPharmD, BCOP
Director, Clinical Pharmacy Services, Dana-Farber Cancer Institute
 
ACPE UAN
0280-0000-19-008-L01-P (Knowledge-Based)
0280-0000-19-008-L01-T (Knowledge-Based)
0280-0000-19-008-L01-N (Knowledge-Based)
 
Credits
1.5
 
Handouts
 
Supported By
American Health Resources, LLC.
 
This presentation will provide an overview of the services offered by the Regional Center for Poison Control and Prevention serving Massachusetts and Rhode Island. The main service offered is the Poison Help Hotline, 1-800-222-1222. Pharmacists will learn when to call and when to refer people to call the Poison Help Hotline in their daily work. Attendees will also learn about the center’s top poisonous substances calls and how to prevent all types of poisonings from occurring by utilizing the best practices for poison prevention. By the end of the presentation, pharmacists will know how to integrate the services offered by the Poison Center into their daily work and help raise awareness of the Poison Help Hotline to their patients.  
 
 
Pharmacist Learning Objectives
  • Recognize the function of the poison center as a resource and all that the poison center does.
  • Identify recent poison data and trends
  • Recognize how pharmacists may integrate the Poison Help hotline service into contemporary pharmacy practice.
Pharmacy Technician Learning Objectives
  • Recognize the function of the poison center as a resource and all that the poison center does.
  • Identify recent poison data and trends
  • Recognize how pharmacists may integrate the Poison Help hotline service into contemporary pharmacy practice.
Nurse Learning Objectives
  • Recognize the function of the poison center as a resource and all that the poison center does.
  • Identify recent poison data and trends
  • Recognize how pharmacists may integrate the Poison Help hotline service into contemporary pharmacy practice.
 
Faculty
Cheryl LangMPH
Education Coordinator, Massachusetts and Rhode Island Regional Center for Poison Control
 
ACPE UAN
0280-0000-19-003-L04-P (Knowledge-Based)
0280-0000-19-003-L04-T (Knowledge-Based)
0280-0000-19-003-L04-N (Knowledge-Based)
 
Credits
1
 
Handouts
 
Supported By
Connecticut Poison Prevention Center
 
Nuclear pharmacy is a little understood niche and realm within the profession of pharmacy.  This session seeks to introduce the participant to the concepts of nuclear pharmacy diagnostics.  It will explore the daily functions of a nuclear pharmacist and highlight key drugs used in nuclear pharmacy practice.  Safety considerations of working in a nuclear pharmacy will be discussed, as will traditional career paths of nuclear pharmacists.
 
 
Pharmacist Learning Objectives
  • Identify the source of commonly used radioisotopes for medical imaging
  • Identify relevant radiation safety practices employed by nuclear pharmacists
  • Identify the mechanism of action for common nuclear medicine radiotracers
Pharmacy Technician Learning Objectives
  • Identify the source of commonly used radioisotopes for medical imaging
  • Identify relevant radiation safety practices employed by nuclear pharmacists
  • Identify the mechanism of action for common nuclear medicine radiotracers
Nurse Learning Objectives
  • Identify the source of commonly used radioisotopes for medical imaging
  • Identify relevant radiation safety practices employed by nuclear pharmacists
  • Identify the mechanism of action for common nuclear medicine radiotracers
 
Faculty
Kevin HopeRPh
Clinical Education Specialist and Continuing Education Administrator, PharmCon, Inc.; Advisory Board Member, Paradigm Education Solutions; Nuclear Pharmacist, Triad Isotopes
 
ACPE UAN
0280-0000-19-010-L04-P (Knowledge-Based)
0280-0000-19-010-L04-T (Knowledge-Based)
0280-0000-19-010-L04-N (Knowledge-Based)
 
Credits
1
 
Handouts
 
Supported By
American Health Resources, LLC.
 
These are cases from all over the country although I try to focus on Massachusetts cases.  I will have comparative claims data from our insurer and a larger consortium of insurers to compare pharmacy claims with other types of malpractice claims.  I will discuss recent legal change in Massachusetts with regard to disclosure of adverse events and describe our process for disclosing an event at BWH.  I will review a few of the current pharmacy bills the Massachusetts legislature is considering this two year session.  I will review some of the draft regulation and newer regulations that the Massachusetts Board of Pharmacy is or has adopted.  Then I will focus on sterile compounding and discuss the changes made by the Board of Pharmacy so far and those regulatory changes that are in the pipeline and will become enforceable soon.
 
 
Pharmacist Learning Objectives
  • Recognize the implications of pharmacy malpractice claims data from insurers
  • Identify the process for disclosure of adverse events
  • Identify recent regulatory changes by the Massachusetts Board of Pharmacy
  • Identify relevant draft regulations on sterile and non-sterile compounding by the Massachusetts Board of Pharmacy
Pharmacy Technician Learning Objectives
  • Recognize the implications of pharmacy malpractice claims data from insurers
  • Identify the process for disclosure of adverse events
  • Identify recent regulatory changes by the Massachusetts Board of Pharmacy
  • Identify relevant draft regulations on sterile and non-sterile compounding by the Massachusetts Board of Pharmacy
Nurse Learning Objectives
  • Recognize the implications of pharmacy malpractice claims data from insurers
  • Identify the process for disclosure of adverse events
  • Identify recent regulatory changes by the Massachusetts Board of Pharmacy
  • Identify relevant draft regulations on sterile and non-sterile compounding by the Massachusetts Board of Pharmacy
 
Faculty
David SeaverRPh, JD
Senior Risk Manager, Brigham & Women's Hospital
 
ACPE UAN
0280-0000-19-007-L03-P (Knowledge-Based)
0280-0000-19-007-L03-T (Knowledge-Based)
0280-0000-19-007-L03-N (Knowledge-Based)
 
Credits
2
 
Handouts
 
Supported By
American Health Resources, LLC.
 
Anticoagulant therapy is the cornerstone intervention for the prevention and treatment of thrombosis. The introduction of direct oral anticoagulants (DOACs), apixaban, betrixaban, dabigatran, edoxaban, and rivaroxaban, beginning in 2008 has made therapy easier and safer for both physician and patient. Since their Food and Drug Administration (FDA) approvals, clinical trial information has continued to emerge showing benefit in certain patient populations, while showing potential harm in others. The pharmacist is in a unique position to evaluate anticoagulant therapy, identify appropriate selection, dose and duration of therapy while providing instruction and educations to patients. In this educational module we will review existing FDA approved indications but focus on new and potential indications where DOACs were either rarely used or omitted from therapy.    
 
 
Pharmacist Learning Objectives
  • Recognize appropriate indications for direct oral anticoagulant (DOAC) therapy.
  • Identify patient populations with cardiovascular disease that would benefit from DOAC therapy.
  • Identify appropriate DOAC selection, dosing, and duration of therapy in these patients.
Pharmacy Technician Learning Objectives
  • Recognize appropriate indications for direct oral anticoagulant (DOAC) therapy.
  • Identify patient populations with cardiovascular disease that would benefit from DOAC therapy.
  • Identify appropriate DOAC selection, dosing, and duration of therapy in these patients.
Nurse Learning Objectives
  • Recognize appropriate indications for direct oral anticoagulant (DOAC) therapy.
  • Identify patient populations with cardiovascular disease that would benefit from DOAC therapy.
  • Identify appropriate DOAC selection, dosing, and duration of therapy in these patients.
 
Faculty
John FanikosRPh, MBA
Executive Director of Pharmacy Services, Brigham and Women's Hospital
 
ACPE UAN
0280-0000-19-006-L01-P (Knowledge-Based)
0280-0000-19-006-L01-T (Knowledge-Based)
0280-0000-19-006-L01-N (Knowledge-Based)
 
Credits
1.5
 
Handouts
 
Supported By
American Health Resources, LLC.
 
 
 
 
Requirements for CE Credit
  • Participant Requirement and Statement of Credit: To receive credit, participants must fully attend each session (no partial credit will be awarded), pass in a completed attendance verification form, and using the access code provided, complete the online evaluation for each session attended. Attendance will be verified. All participants will have the opportunity to evaluate the educational sessions and presenters as well as the ability to identify their
  • Pharmacists and Pharmacy Technicians: CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours where an official certificate of credit can be printed. Evaluations must be completed within 60 days of program date to receive credit.
  • Statement of Disclosure: Disclosure will be made on the day of the program regarding any interest or affiliation a speaker may have with a supporting organization.
  • Refund Policy: A full refund will be provided only if a written request is received by American Health Resources, LLC at least 48 hours prior to the program or if the program is cancelled. American Health Resources, LLC reserves the right to change the presenters, topics or seminar schedules.
 
Only Certificates of Credit issued from CPE Monitor are valid in the US.
CPE Monitor will not accept credits after 60 days from the session date.
 
Supported By:
American Health Resources, LLC.
 
Registration closes on 4/30/2019 at 11:00 PM
 

CONTINUING EDUCATION

843 488 5550 Office

843 488 5554 Fax

info@ahrevents.com Email

www.ahrevents.com Web

341 Wellness Drive, Myrtle Beach, SC 29579 Address

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyAmerican Health Resources, LLC a subsidiary of PharmCon, Inc.
Developed By: ITB, Inc.